Original Research

Published on 27 Sep 2023

177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry

in Pharmacology of Anti-Cancer Drugs

Ayman Abouzayed
Kamila Seitova
Fanny Lundmark
Vitalina Bodenko
Maryam Oroujeni
Vladimir Tolmachev
Ulrika Rosenström
Anna Orlova

Frontiers in Oncology

doi 10.3389/fonc.2023.1221103

4,498 views
2 citations

Case Report

Published on 22 Sep 2023

Case Report: A rare case of non-small cell lung cancer with STRN-ALK fusion in a patient in very poor condition treated with first-line ensartinib

in Pharmacology of Anti-Cancer Drugs

Guo-qiang Song
Yi-zhong Li
Weiliang Kong
Guo-qiang Hu

Frontiers in Oncology

doi 10.3389/fonc.2023.1235679

1,927 views

Original Research

Published on 05 Sep 2023

Prognostic and therapeutic implications of iron-related cell death pathways in acute myeloid leukemia

in Pharmacology of Anti-Cancer Drugs

Tongyu Li
Tongtong Lin
Jiahao Zhu
Miao Zhou
Shufang Fan
Hao Zhou
Qitian Mu
Lixia Sheng
Guifang Ouyang

Frontiers in Oncology

doi 10.3389/fonc.2023.1222098

2,156 views

Original Research

Published on 29 Aug 2023

Cell cycle arrest and apoptotic studies of Terminalia chebula against MCF-7 breast cancer cell line: an in vitro and in silico approach

in Pharmacology of Anti-Cancer Drugs

Pruthvish Reddy
Sushma Pradeep
Gopinath S. M.
Chandan Dharmashekar
Disha G.
Sai Chakith M. R.
Chandrashekar Srinivasa
Ali A. Shati
Mohammad Y. Alfaifi
Serag Eldin I. Elbehairi

Frontiers in Oncology

doi 10.3389/fonc.2023.1221275

3,601 views

Original Research

Published on 28 Aug 2023

High quantum efficiency ruthenium coordination complex photosensitizer for improved radiation-activated Photodynamic Therapy

in Pharmacology of Anti-Cancer Drugs

Abul Kalam Azad
Lothar Lilge
Nawaid H. Usmani
John D. Lewis
Houston D. Cole
Colin G. Cameron
Sherri A. McFarland
Deepak Dinakaran
Ronald B. Moore

Frontiers in Oncology

doi 10.3389/fonc.2023.1244709

2,363 views
1 citation

Correction

Published on 25 Aug 2023

Corrigendum: Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity

in Pharmacology of Anti-Cancer Drugs

Qian Zhao
Shan-Shan Xiong
Can Chen
Hong-Ping Zhu
Xin Xie
Cheng Peng
Gu He
Bo Han

Frontiers in Oncology

doi 10.3389/fonc.2023.1259550

969 views

Correction

Published on 25 Aug 2023

Corrigendum: Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study

in Pharmacology of Anti-Cancer Drugs

Daling Dong
Shixin Zhang
Bin Jiang
Wei Wei
Chao Wang
Qian Yang
Tingzhi Yan
Min Chen
Liken Zheng
Weikang Shao

Frontiers in Oncology

doi 10.3389/fonc.2023.1275851

902 views

Editorial

Published on 23 Aug 2023

Editorial: Pharmaceutically targeting hypoxia in the breast cancer microenvironment: mechanistic and translational approaches

in Pharmacology of Anti-Cancer Drugs

Manjari Singh
Manash K. Paul
Subhadeep Roy

Frontiers in Oncology

doi 10.3389/fonc.2023.1265523

918 views

Original Research

Published on 21 Aug 2023

COVID−19 hospitalization increases the risk of developing glioblastoma: a bidirectional Mendelian-randomization study

in Pharmacology of Anti-Cancer Drugs

Jiajun Dong
Shengnan Wang
Haoqun Xie
Yanhao Mou
Hao Zhu
Yilong Peng
Jianxin Xi
Minggu Zhong
Zhengyuan Xie
Zongyuan Jiang

Frontiers in Oncology

doi 10.3389/fonc.2023.1185466

9,297 views
2 citations

Brief Research Report

Published on 14 Aug 2023

Neurological adverse events of mitotane in adrenocortical carcinoma: results of a pilot study

in Pharmacology of Anti-Cancer Drugs

Marilda Mormando
Edvina Galiè
Marta Bianchini
Rosa Lauretta
Giulia Puliani
Antonio Tanzilli
Umberto Anceschi
Giuseppe Simone
Gianluca Petreri
Giuliana Graziano

Frontiers in Oncology

doi 10.3389/fonc.2023.1222002

1,771 views
1 citation

Review

Published on 10 Aug 2023

A new approach to overcoming resistance to immunotherapy: nanotechnology

in Pharmacology of Anti-Cancer Drugs

Jiangbo Shao
Ying Jin
Chunxiang Jin

Frontiers in Oncology

doi 10.3389/fonc.2023.1210245

2,359 views
5 citations

Original Research

Published on 08 Aug 2023

CCDC43 as a potential therapeutic target of Tian Yang Wan for the treatment of hepatocellular carcinoma by activating the hippo pathway

in Pharmacology of Anti-Cancer Drugs

Mingyuan Tao
Dongwei Han
Siyu Wei
Changyu Gao

Frontiers in Oncology

doi 10.3389/fonc.2023.1232190

2,061 views
1 citation

Case Report

Published on 02 Aug 2023

Chemotherapy-induced toxic epidermal necrolysis in a patient with multiple myeloma, a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Rui X
Meidan W
Gongqiang W
Longyi Z
Xiaoxia W
Wei C
Chenhui W

Frontiers in Oncology

doi 10.3389/fonc.2023.1227448

2,565 views
2 citations

Review

Published on 31 Jul 2023

Targeting MCL-1 protein to treat cancer: opportunities and challenges

in Pharmacology of Anti-Cancer Drugs

Shady I. Tantawy
Natalia Timofeeva
Aloke Sarkar
Varsha Gandhi

Frontiers in Oncology

doi 10.3389/fonc.2023.1226289

6,904 views
18 citations

Original Research

Published on 26 Jul 2023

Preclinical PK investigation of a novel IDO1/TDO dual inhibitor—SHR9146 in mouse plasma and tissues by LC-MS/MS

in Pharmacology of Anti-Cancer Drugs

Mei Xiao
Kan Zhong
Li Guo
Wei Li
Xiaoli Wang
Zhenjun Qiu
Taijun Hang

Frontiers in Oncology

doi 10.3389/fonc.2023.1191778

1,604 views
1 citation

Opinion

Published on 24 Jul 2023

Tyrosine kinase inhibitors, ionic currents, and cardiac arrhythmia

in Pharmacology of Anti-Cancer Drugs

Chi-Hao Hu
Sheng-Nan Wu
Edmund Cheung So

Frontiers in Oncology

doi 10.3389/fonc.2023.1218821

1,990 views
4 citations

Navigation group

Articles

177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry

Case Report: A rare case of non-small cell lung cancer with STRN-ALK fusion in a patient in very poor condition treated with first-line ensartinib

Prognostic and therapeutic implications of iron-related cell death pathways in acute myeloid leukemia

Cell cycle arrest and apoptotic studies of Terminalia chebula against MCF-7 breast cancer cell line: an in vitro and in silico approach

High quantum efficiency ruthenium coordination complex photosensitizer for improved radiation-activated Photodynamic Therapy

Corrigendum: Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity

Corrigendum: Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study

Editorial: Pharmaceutically targeting hypoxia in the breast cancer microenvironment: mechanistic and translational approaches

COVID−19 hospitalization increases the risk of developing glioblastoma: a bidirectional Mendelian-randomization study

Neurological adverse events of mitotane in adrenocortical carcinoma: results of a pilot study

A new approach to overcoming resistance to immunotherapy: nanotechnology

CCDC43 as a potential therapeutic target of Tian Yang Wan for the treatment of hepatocellular carcinoma by activating the hippo pathway

Chemotherapy-induced toxic epidermal necrolysis in a patient with multiple myeloma, a case report and literature review

Targeting MCL-1 protein to treat cancer: opportunities and challenges

Preclinical PK investigation of a novel IDO1/TDO dual inhibitor—SHR9146 in mouse plasma and tissues by LC-MS/MS

Tyrosine kinase inhibitors, ionic currents, and cardiac arrhythmia